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doi:10.1016/j.ejvs.2010.11.029Abstract Objectives: The small saphenous vein (SSV) lies in close relationship with sural
nerve and is at risk of damage during surgery or vein ablation procedures on this vein. The
aim of this study was to compare the effect of puncture site for SSV endovenous laser ablation
(EVLA) on the rate of post-operative sural nerve injury.
Design: Randomised controlled study.
Patients and Methods: Sixty patients with isolated SSV varicose veins (68 limbs) were rando-
mised into two groups. All patients were treated with endovenous laser ablation procedures
using radial fibres and a 1470 nm diode laser. In Group 1, SSVs were canulated from lateral mal-
leolar part of the SSV. In Group 2, SSVs were canulated in the mid-calf. EVLA procedures were
performed by using 12 W energy and 70 J cm1 LEED (linear endovenous energy density). Local
pain, ecchymosis, induration and paraesthesia in treated regions, vein diameter, treated vein
length, tumescent anaesthesia volume, delivered energy were recorded. Follow-up visits were
arranged on the 2nd post-operative day, 7th day, 1st, 2nd, 3rd and 6th months.
Results: The mean SSV diameters at sapheno-popliteal junction (SPJ) and calf levels were
Group 1 SPJ: 6.6 S.D. 1.2 mm, Calf: 5.1 S.D. 1.1 mm, and Group 2 SPJ: 6.8 S.D. 1.6 mm, Calf:
4.9 S.D. 1.3 mm. Adverse events after treatment were 1 patient with induration, 3 with ecchy-
mosis and 6 minimal paraesthesia in Group 1 (malleolar) and 1 local pain, 4 minimal ecchymosis
or induration and 1 paraesthesia in Group 2 (mid-calf). In Group 1 in two patients the paraes-
thesia lasted 2 months and then resolved spontaneously. In the remaining four patients’
paraesthesia resolved in less than 1 month without treatment. In Group 2 paraesthesia
resolved spontaneously in two weeks. Induration, ecchymosis and local pain also resolved in
less than 2 weeks in both groups. There was no recanalisation or reflux in the treated SSV of
either group during the follow-up period.ATA Kalp Damar Cerrahisi AD, 06010 Etlik/Ankara, Turkey. Tel.:þ905424367502; fax:þ903124666465.
oo.com (S. Doganci).
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Nerve Injuries after Small Saphenous Vein EVLA 401Conclusion: Treatment of the SSV by endovenous laser ablation using a 1470 nm laser and
a radial fibre is safe and effective. Puncturing the vein at mid-calf level causes less post-oper-
ative nerve injury without affecting the recanalisation rates.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Venous valvular incompetence in the lower limb is a common
medical condition afflicting 25% of women and 15% of men in
theUnited States and in Europe.1 Great saphenous vein (GSV)
reflux is the most common underlying cause of significant
varicose veins. Sapheno-popliteal incompetence and small
saphenous vein reflux, although less common than GSV
reflux, may result in symptoms of equal severity.2,3 Surgery
for the incompetent small saphenous veins (SSV) is more
challenging, with more complications than for the GSV.1
Conventional surgery for SSV incompetence results in
a high incidence of recurrence (up to 52% at 3 years) and is
frequently associated with neurovascular injury.4 In many
instances this is the result of inaccurate ligation of sapheno-
popliteal junction (SPJ).5 Even in experienced hands
sapheno-popliteal ligation is not always technically success-
ful. This is mainly due to the diverse anatomic anomalies of
the SPJand its proximity to the tibial and sural nerves.6 Unlike
the saphenofemoral junction of GSV which is almost
constant, the SPJ is variable in terms of level, site of
attachment to the popliteal vein, as well as termination and
tributaries.7 Rashid et al.8 have shown that ligation of the SPJ
is not achieved in 30% of the cases, even if the junction is
marked pre-operatively under ultrasound guidance. The
incision made in the popliteal fossa is associated with wound
healing problems and infection in 19e23% of cases.6
The SSV lies in close relationship with surrounding
nerves. Above the popliteal fossa the thigh extension of the
SSV is in contact with posterior femoral nerve (small sciatic
nerve). In the popliteal fossa the termination of the SSV can
be in contact with tibial or common peroneal nerves. When
the SSV ends above the popliteal skin crease and is dis-
placed laterally, the risk of nerve injury is increased. Below
the popliteal crease, the sural nerve can join the SSV at
variable level and at the ankle the nerve is always in
contact with the SSV and may be wrapped around it.7
Minimally invasive techniques have been developed as
alternatives to surgery in an attempt to reduce morbidity
and improve recovery time following varicose vein surgery.
Endovenous laser ablation (EVLA) is one of the most
promising of these new techniques.9,10 This procedure has
proved itself in the treatment of incompetent GSVs with
high success rates (88e100%).11 That EVLA may provide
a more effective treatment for SPJ and SSV reflux is sug-
gested by poor results from surgery, the accurate visuali-
zation of the SPJ with ultrasound during EVLA, allowing
ablation of SSV from this point distally, and the possibility
that laser ablation reduces the risk of neovascularisation.5
In some studies temporary paraesthesia is reported as
frequently as in 40% of limbs following the EVLA for the SSV.3
The principal hypothesis of this study was that puncturing
the SSV at the most distal point may increase post-operative
nerve injury due to close relationship between SSV and thesural nerve at level of ankle. The aim of the study was to
compare the effect of puncture site for EVLA of the SSV on
post-operative sural nerve injury.
Patients and Methods
The study was approved by our institutional ethics co-
mmittee and informed written consent was obtained from
patients. Between September 2009 and January 2010, 69
patients presenting with symptomatic varicose veins sus-
pected of arising from the SSV were considered for inclusion
in the study which was undertaken at Gulhane Military
Academy of Medicine, Department of Cardiovascular
Surgery. All patients were examined clinically and with
duplex ultrasound (US) imaging using a LOGIC Book XP (GE
Healthcare, Buckinghamshire, UK) system to assess the
deep and superficial veins of both lower limbs to allow the
Clinical Etiological Anatomical Pathological (CEAP)12 clas-
sification to be assessed for each patient. The diameter of
the SSV was measured at the level of the SPJ and at the calf
(in the muscular part of the gastrocnemius muscle).
Patients with a history of previous DVT, concomitant
peripheral arterial disease (ABPI <0.8), difficulty in ambu-
lation, pregnant or breast-feeding, recurrent varicose veins
and those who had reflux in other axial veins (anterior
accessory great saphenous vein, GSV) or perforators were
excluded from the study. Patient progress through this
study is shown in a CONSORT diagram (Fig. 1).
Nine patients were excluded from the study. Of these,
six had additional reflux in the GSV, one was pregnant, one
had a history of previous DVT, and one had additional
peripheral arterial disease.
The remaining 60 patients (68 limbs) were randomised
into two groups according to a computer-generated ran-
domisation list. In Group 1, SSVs were canulated from the
lateral malleolar part. In Group 2, SSVs were canulated
from the mid-calf part of SSV. All patients were treated
with the 1470 nm diode laser (Biolitec AG, Germany) and
radial laser fibre (Elves radial, Bolitec AG, Bonn, Germany).
Primary outcome of the study was to compare
post-operative nerve injury assessed by the extent of
paraesthesia. Secondary outcomes were post-operative
ecchymoses, pain, induration, return to daily activity and
rate of recanalisation.
Procedure
All patients underwent EVLA under intravenous midazolam
sedation with oxygen supplementation. All SSVs were
canulated percutaneously with a 16-gauge needle under US
control (In Group 1: lateral malleolar part, in Group 2: mid-
calf part (muscular part of gastrocnemius muscle)). Then
a guide-wire was inserted through the needle and a 6-F
introducer sheath (INPUT Intraducer sheath, Medtronic
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Figure 1 Consort flow diagram of the study.
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placed over the guide-wire into the SSV. Radial laser fibres
were inserted through the sheaths. The tip of the laser fibre
was positioned 2e3 cm below the SPJ under US guidance.
The main factors for determining this point were that the
tip was placed beneath the fascia, and at a safe distance
from the SPJ.
Perivenous tumescent local anaesthesia (TLA) (1000 ml
saline 0.9%, 50 ml lidocaine 2%, 1 ml Epinenephrine 1:1000,
10 mEq NaHCO3) was given under US control (10 ml/treated
vein segment). Laser energy was applied using the laser’s
continuous mode and a constant pullback with a rate cor-
responding to 70 J cm1 linear endovenous energy density
(LEED). In both groups, laser power was set to 12 W and
total laser energy was recorded. After removing the fibre,
closure of the SSV was confirmed by US.
Concomitant phlebectomies were not performed in
either group (with the rationale of being a confounding
factor for determining the exact rate of paraesthesia) and
a compression bandage was applied over the course of the
treated vein for 24 h. Patients then wore class II graduated
compression stockings (23e32 mmHg, knee-high) for the
next four weeks. Prophylactic low-molecular-weight
heparin was not used in either group. Patients were advised
to walk regularly during recovery from treatment and
diclofenac 75 mg twice daily as required was prescribed for
analgesia.
Follow-up examinations
Patients were evaluated on the 2nd day, 1st week, 1st
month, 2nd, 3rd, and 6th month both clinically and with
duplex scan for treatment related side effects and com-
plications in addition to closure rate. The presence ofecchymoses, palpable induration, paraesthesia, pain, skin
necrosis, deep vein thrombosis was recorded. The duration
of all symptoms was also recorded.
Sample size
Published literature in this field contains conflicting rates of
post-operative nerve injury following endovenous laser
ablation of the SSV. Some studies report frequencies as high
as 40%.1 From our previous experience with the 1470 nm
laser and radial fibre we predicted a 30% paraesthesia rate
in Group 1 (malleolar canulation). Using the mid-calf can-
ulation site in Group 2 we predicted a rate of 6% of
paraesthesia. To detect this difference with an alpha error
of 5% and 80% of power (20% of beta error), we needed to
enter at least 31 limbs per each group.13
Statistical analysis
Recurrence, post-operative complications, morbidity and
side-effect rates were compared between groups using
Fisher’s exact test andPearsoncorrelation.Ap valueof<0.05
was considered significant. All analyseswere performedusing
the statistical package SPSS forWindows version 15.0 (SPSS,
Chicago, IL, USA).
Results
A total 69 patients were seen for SSV treatment between the
study periods. Nine of themwere excluded from the study as
previously mentioned. A total of 33 limbs of 30 patients in
Group 1 and 35 limbs of 30 patients in Group 2 were treated.
Successful percutaneous access and endovenous placement
Table 1 Preoperative patients’ demographics.
Parameters Group I (malleolar)
(N Z 30)
Group II (mid-calf)
(N Z 30)
P value
Number of treated limbs 33 35 NS
Gender (M/F) 12/18 14/16 NS
Mean age (years) 31.2 S.D. 6.23 33.3 S.D. 5.43 NS
Mean SSV diameter (mm)
SPJ level 6.6 S.D. 1.2 6.8 S.D. 1.6 NS
Calf level 5.1 S.D. 1.1 4.9 S.D. 1.3 NS
Mean reflux duration at SPJ (s) 5.6 S.D. 2.1 5.4 S.D. 1.9 NS
CEAP classification/limb
C2 22 24 NS
C3 8 10 NS
C4 2 1 NS
Ep 33 35 NS
M: Male, F: Female, SSV: Small saphenous vein, SPJ: Sapheno-popliteal junction, mm: Millimetre, s: Seconds, NS: Not significant S.D.:
Standard deviation CEAP: Clinical etiological anatomic pathological.
Nerve Injuries after Small Saphenous Vein EVLA 403of the laser fibre were achieved in all patients. Demographic
details and results of preoperative clinical and US examina-
tions are shown in Table 1. The two groups of patients are
very similar.
Operative data are shown in Table 2. Our aim was to
achieve a LEED of 70 J cm1 and this appears to have been
achieved in both groups. However, due to the different
levels of puncture there were statistically significant
differences in the total amount of energy and TLA
volumes as it is expected. The TLA volume was approxi-
mately 10 ml per treated centimetre, which we consider
to be optimum in minimising post-operative ecchymosis
and paraesthesia.
No patient was lost from this series during the 6-month
follow-up period. No evidence of residual flow or venous
reflux was found on US imaging at any time during follow-up.
Table 3 summarises the side effects and other assess-
ments of the outcome of this clinical trial. The most
frequent side effects in both groups were ecchymosis and
induration. Temporary paraesthesia as the primary
outcome of the study was more frequent in group 1 (6
patients vs 1 patient, p < 0.05 Fisher’s exact test). Severe
complications such as deep vein thrombosis (DVT), pulmo-
nary embolism (PE), skin burns, and motor nerve lesions did
not occur in any limb. Assessments of post-operative pain
included duration of pain and need for analgesia, both ofTable 2 Operative data.
Parameters Group I (m
(N Z 30)
Mean treated SSV length (cm) 25.8 S.D.
Laser power (W) 12
LEED (J/cm) 70
Mean total energy/limb (J) 1806 S.D.
Mean TLA volume/limb (ml) 270 S.D. 3
Mean procedure duration/limb (min) 25.1 S.D.
Immediate post-operative closure rate (%) 100
SSV: Small saphenous vein, cm: Centimetres, W: Watt, LEED: Line
anaesthesia S.D.: Standard deviation, NS: Not significant, ml: Millilitrwhich were less in group 2 patients. The mean duration of
ecchymosis was almost 2 weeks in both groups. Subcuta-
neous induration along the treated veins after EVLA was
noticed in 1 limb in group 1 and 2 limbs in group 2. This
lasted for less than 3 weeks in both groups. Paraesthesia in
the region of treated veins was more common in group 1;
but overall symptoms were of minor severity. In Group 1 in
two patients paraesthesia lasted 2 months and then
resolved spontaneously. In the remaining four patients,
paraesthesia disappeared in less than 1 month without
treatment. In Group 2 paraesthesia resolved spontaneously
in two weeks.
Following the post-operative second month visit, scle-
rotherapy of saphenous tributaries was performed in 54
patients and 6 patients underwent phlebectomy.
Discussion
Surgery for SSV is more challenging, with more complica-
tions and higher recurrence rates than for great saphenous
veins. One of the major causes of recurrence is failure to
identify the SPJ.14 In a study which analysed the outcome
of 59 SSV operations showed that there was failure to
identify and ligate the SPJ in 13 (22%) patients, despite
preoperative duplex scanning. This along with a major
complication rate of 5%, prompted a suggestion that smallalleolar) Group II (mid-calf)
(N Z 30)
P value
3.2 17.9 S.D. 1.9 <0.001
12 NS
70 NS
224 1253 S.D. 133 <0.001
5 180 S.D. 25 <0.001
4.4 21.4 S.D. 5.2 NS
100 NS
ar endovenous energy density J: Joule, TLA: Tumescent local
es, min: Minutes.
Table 3 Post-operative data.
Parameters Group I (malleolar)
(N Z 30)
Group II (mid-calf)
(N Z 30)
P value
Pain duration (day) 2.6 2.1 P < 0.05
Duration of analgesia need (day) 6.2 4.8 P < 0.05
Induration 1 2 NS
Ecchymosis 3 2 NS
Skin necrosis 0 0 NS
Skin burn 0 0 NS
Paraesthesia 6 1 P < 0.05
Deep vein thrombosis 0 0 NS
Pulmonary Embolus 0 0 NS
Return to daily activity (day) 1.8 1.3 P < 0.05
Duration of compression stockings (day) 35.2 S.D. 14.4 32.6 S.D. 15.1 NS
6th month closure rate (%) 100 100 NS
S.D.: Standard deviation, NS: Not significant.
404 S. Doganci et al.saphenous varicose veins should be managed using alter-
native treatment modalities.15,16
Endovenous laser treatment is another minimal invasive
technique for ablation of incompetent saphenous veins.
EVLA of GSV has been widely accepted as a treatment for
primary varicose veins, but is less often used in the treat-
ment of SSV reflux.1 Reluctance of practitioners to use EVLA
in SSV incompetence may be related to concerns about the
proximity to the sural nerve to the vein as well as concerns
about popliteal thrombosis.17
The temperature at the tip of the laser fibre may reach
720 C and although tumescent anaesthesia reduces heat
transfer to adjacent tissue irreversible nerve injury may
occur at temperatures above 45 C. In a previous study
measurements adjacent to the GSV have confirmed that
following adequate infiltration of tumescent anaesthesia
the perivenous temperature reaches a median of 34.5 C
and thus nerve injury should be avoided.5
There are conflicting results about the post-operative
paraesthesia rates in the literature. Theivacumar et al.5
reported 3 temporary paraesthesia in a group 65 SSV
patients. However, Desmytte`re et al.1 reported a 40%
temporary paraesthesia in a 147-patient series. When these
conflicting results were analysed, in Theivacumar’s study
the canulation site was mid-calf or higher. They used
810 nm diode laser, 12 W laser energy and a LEED of
60e72 J cm1. In the Desmytte`re’s group, they canulated
the SSVs from mid-to-lower calf. A 980 nm laser, 10 W
energy and various LEEDs (50e90 J cm1) were used.
Although Desmytte`re’s group used less energy (10 W vs
12 W) and a higher wavelength (980 nm vs 810 nm), their
paraesthesia results were dramatically higher than repor-
ted in Theivacumar’s study. In Desmytte`re’s group, there is
no subgroup analysis to assess at which LEED the paraes-
thesia rate is increased. The main difference seems at the
puncture levels. In our study we used 1470 nm laser, 12 W
energy and a LEED of 70 J cm1 in both groups and only one
temporary paraesthesia was observed in group 2 (while 6
temporary paraesthesiae were observed in group 1). Since
we did not perform concomitant phlebectomies in both
groups, this difference must be related to the level of the
puncture site.In our previous study, we used 1470 nm and a LEED of
90 J cm1 for treatment of incompetent GSVs. Only one
paraesthesia in the 1470 nm group in 54 limbs was
observed.18 The initial results of the 1470 nm laser wave-
length reported by Pannier et al.19 found a 9.5% paraes-
thesia rate using a LEED of more than 100 J cm1. However
they did not perform a subgroup analysis for 26 SSVs and the
paraesthesia rate in this group.
When compared with other studies, LEED used in our
study appears to be appropriate. When using the 980 nm
diode laser, LEED reported by Park and Yim varied between
62 J cm1 and 77 J cm1.20 Similarly in a study performed
by Park and Hwang, LEED was adjusted to between
50 J cm1 and 60 J cm1.14
The length of vein treated in our study was 25.8 S.D.
3.2 cm and 17.9 S.D. 1.9 cm in group 1 and 2 respectively
(p < 0.001). These results were similar to literature. Huis-
man et al.6 reported the mean treated vein length was
reported as 23 cm. Desmytte`re1 reported the length of vein
treated as 18.2 S.D. 8.3 cm. Although there is a significant
difference between our groups, this was due to the
different levels of the puncture sites.
The clinical outcome of EVLA in the SSV has been
reported in a few studies. In Park’s series, four of 93 SSVs
re-canalised with the recurrence of reflux at 1-month
follow-up. Continued closure of the SSV was seen in all of 87
limbs at the 3 month, all of 82 limbs at the 6 month, all of
77 limbs at the 1 year, all of 71 limbs at the 2 year and all of
55 limbs at the 3 year follow-up which were available in the
follow-up.14 Desmytte`re et al.1 reported 3 re-canalisations
in 117 limbs which are available at the 1 year follow-up.
These re-canalisations were observed in the veins greater
than 9-mm diameter. In our study the recanalisation rate
was the secondary endpoint of the study. However, there
was no recanalisation in either group during the 6-month
follow-up.
The incidence of ecchymoses in our study was 3 and 2 in
group 1 and 2 respectively. This rate was lower than the
Desmytte`re’s study (60% in the first week). Desmytte`re’s
group performed concomitant phlebectomies in 39% of the
patients.1 However they did not evaluate the effect of this
extra procedure over the rate of ecchymoses. The rate in
Nerve Injuries after Small Saphenous Vein EVLA 405Park’s study was 27% (26 in 95 limbs).14 This group did not
perform concomitant phlebectomies. However our rates
are also lower than this group. According to our previous
experience, this difference may be the effect of the
wavelength.
Duration of pain, the need for analgesia and the return
to daily activity were significantly lower in group 2.
Although there is no scientific evidence, the difference may
be related to the treated vein length.
EVLA offers many potential advantages over conven-
tional surgery for SSV reflux: the procedure is performed
on-table US imaging, giving safe and reliable identification
of the variable anatomy. It is likely that the role of surgery
will diminish as the endovenous methods such as EVLA
become more widely used.
Conclusion
Due to its very close relationship with sural nerve in the
course at the distal calf to the ankle, puncturing the SSVs at
the mid-calf part may decrease post-operative paraesthesia
that is one of the important litigation claims21 following the
SSV surgery without affecting the recanalisation rates.
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